Li Q, Inagaki H, Minami M
Department of Hygiene and Public Health, Nippon Medical School, Tokyo, Japan.
Arch Toxicol. 1996;70(7):414-9. doi: 10.1007/s002040050293.
We evaluated cross-sensitization between p-phenylenediamine (pPDA) and p-aminophenol (pAP) or m-phenylenediamine (mPDA) by a modified lymphocyte transformation test. Guinea pigs were sensitized with pPDA using the maximization test procedure. Lymph node cells from the animals were then cultured with pPDA, pAP or mPDA in the presence or absence of epidermal cells (EC). Transformed lymphocyte counts were evaluated by means of 3H-thymidine uptake. Non-sensitized guinea pigs were used as controls. Blastogenesis in lymphocytes from sensitized guinea pigs was enhanced when cultured with pPDA, pAP or mPDA in the absence or presence of EC than without the sensitizers, and the extent of response depended on the concentration of pPDA, pAP or mPDA added to the cultures. Blastogenesis in lymphocytes from control animals was not significantly enhanced in response to pPDA, pAP or mPDA in the presence or absence of EC. The extent of the response to pPDA was greater than that to pAP, which in turn was greater than that to mPDA. In contrast, because pPDA, pAP and mPDA are color developing agents, cross-sensitization between pPDA and pAP or mPDA could not be evaluated by the results of an in vivo challenge due to pigmentation in the patch application sites. The results suggested that there is cross-sensitization between pPDA and pAP or mPDA, and that the modified lymphocyte transformation test is a useful predictive means of detecting cross-sensitization among chemicals, especially for color developing agents.
我们通过改良的淋巴细胞转化试验评估了对苯二胺(pPDA)与对氨基酚(pAP)或间苯二胺(mPDA)之间的交叉致敏作用。采用最大化试验程序用pPDA使豚鼠致敏。然后将这些动物的淋巴结细胞在有或无表皮细胞(EC)存在的情况下与pPDA、pAP或mPDA一起培养。通过3H-胸腺嘧啶核苷摄取来评估转化淋巴细胞计数。未致敏的豚鼠用作对照。与无致敏剂时相比,致敏豚鼠的淋巴细胞在用pPDA、pAP或mPDA培养时,无论有无EC存在,其母细胞生成均增强,且反应程度取决于添加到培养物中的pPDA、pAP或mPDA的浓度。对照动物的淋巴细胞在有或无EC存在的情况下对pPDA、pAP或mPDA的反应未显著增强。对pPDA的反应程度大于对pAP的反应程度,而对pAP的反应程度又大于对mPDA的反应程度。相比之下,由于pPDA、pAP和mPDA是显色剂,由于贴片应用部位的色素沉着,无法通过体内激发试验的结果来评估pPDA与pAP或mPDA之间的交叉致敏作用。结果表明pPDA与pAP或mPDA之间存在交叉致敏作用,且改良的淋巴细胞转化试验是检测化学物质之间交叉致敏作用的一种有用的预测方法,尤其是对于显色剂。